0
Your cart

Your cart is empty

Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries

Buy Now

Drugs for Life - How Pharmaceutical Companies Define Our Health (Paperback) Loot Price: R696
Discovery Miles 6 960
Drugs for Life - How Pharmaceutical Companies Define Our Health (Paperback): Joseph Dumit

Drugs for Life - How Pharmaceutical Companies Define Our Health (Paperback)

Joseph Dumit

Series: Experimental Futures

 (sign in to rate)
Loot Price R696 Discovery Miles 6 960 | Repayment Terms: R65 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In "Drugs for Life," Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. "Drugs for Life" challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.

General

Imprint: Duke University Press
Country of origin: United States
Series: Experimental Futures
Release date: September 2012
First published: September 2012
Authors: Joseph Dumit
Dimensions: 237 x 162 x 18mm (L x W x T)
Format: Paperback
Pages: 280
ISBN-13: 978-0-8223-4871-9
Categories: Books > Social sciences > General
Books > Medicine > General issues > General
Books > Business & Economics > Industry & industrial studies > Manufacturing industries > Pharmaceutical industries
LSN: 0-8223-4871-3
Barcode: 9780822348719

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Empire Of Pain - The Secret History of…
Patrick Radden Keefe Paperback R380 R297 Discovery Miles 2 970
EU Competition Law and Pharmaceuticals
Wolf Sauter, Marcel Canoy, … Hardcover R3,510 Discovery Miles 35 100
The Hard Sell - Crime and Punishment at…
Evan Hughes Paperback R299 R234 Discovery Miles 2 340
Death in Mud Lick - A Coal Country Fight…
Eric Eyre Paperback R479 R396 Discovery Miles 3 960
The Commercialization of Pharmaceutical…
James Hou Hardcover R2,905 Discovery Miles 29 050
Regulation of Synthetic Biology…
Alison McLennan Hardcover R4,088 Discovery Miles 40 880
Empire of Pain - The Secret History of…
Patrick Radden Keefe Paperback R299 R234 Discovery Miles 2 340
Over the Counter Medicines
Alan Maynard, Gerald Richardson Paperback R277 Discovery Miles 2 770
Innovation in the Pharmaceutical…
Takuji Hara Hardcover R3,365 Discovery Miles 33 650
The Hard Sell - Crime and Punishment at…
Evan Hughes Paperback R380 R297 Discovery Miles 2 970
For Blood and Money - Billionaires…
Nathan Vardi Hardcover R809 R653 Discovery Miles 6 530
Advanced Nanoformulations - Theranostic…
Md Saquib Hasnain, Amit Kumar Nayak, … Paperback R4,189 Discovery Miles 41 890

See more

Partners